Oxytocin Buffers Stress Response in Individuals With Impaired Coping Abilities

NCT ID: NCT01065610

Last Updated: 2010-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2008-01-31

Study Completion Date

2008-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigated, if people with impaired coping abilities benefit from intranasal oxytocin application.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coping Skills Oxytocin Stress

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oxytocin

Intranasal Oxytocin, 24 IU

Group Type EXPERIMENTAL

Oxytocin

Intervention Type DRUG

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxytocin

Intervention Type DRUG

Placebo

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male

Exclusion Criteria

* psychological disorders
* drug abuse
* cigarette smoking
* coronary diseases
* nervous system diseases
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Osnabrueck

OTHER

Sponsor Role lead

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Neurolab_RD_001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oxytocin and Social Cognition
NCT01606462 COMPLETED PHASE1
Role of Oxytocin in Telling and Detecting Lies
NCT02361177 WITHDRAWN EARLY_PHASE1
Dog Presence and Oxytocin on Trust Towards Therapists
NCT06248710 RECRUITING PHASE2/PHASE3
Oxytocin and Social Behavior Over the Lifespan
NCT00914953 COMPLETED EARLY_PHASE1
Oxytocin and Emotion Processing
NCT02156661 COMPLETED PHASE1